Aigen Investment Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-28,098
| Closed | -$105K | – | 960 |
|
|
2024
Q1 | $105K | Buy |
+28,098
| New | +$105K | 0.02% | 609 |
|
|
2023
Q4 | – | Sell |
-34,671
| Closed | -$290K | – | 1006 |
|
|
2023
Q3 | $290K | Buy |
34,671
+22,134
| +177% | +$185K | 0.05% | 536 |
|
|
2023
Q2 | $167K | Buy |
+12,537
| New | +$167K | 0.02% | 646 |
|
|
2022
Q2 | – | Sell |
-12,218
| Closed | -$111K | – | 678 |
|
|
2022
Q1 | $111K | Buy |
12,218
+2,073
| +20% | +$18.8K | 0.02% | 494 |
|
|
2021
Q4 | $219K | Buy |
+10,145
| New | +$219K | 0.01% | 906 |
|
|
2021
Q1 | – | Sell |
-35,896
| Closed | -$931K | – | 820 |
|
|
2020
Q4 | $931K | Buy |
+35,896
| New | +$931K | 0.12% | 224 |
|